{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ABEO/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T17:24:39.928Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":8153,"canonical_name":"ABEONA THERAPEUTICS INC.","cik":"0000318306","uei":null,"lei":null,"duns":null,"ticker":"ABEO"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":47},"count":47,"timeline":[{"ts":"2026-09-29","kind":"sec.insider.19608","reporter":"Seshadri Vishwas","title":"Chief Executive Officer","shares":19608,"price_per_share":5.1556,"usd_value":101091,"security_title":"Common Stock","importance":15.1010910048},{"ts":"2026-09-29","kind":"sec.insider.9191","reporter":"Vazzano Joseph Walter","title":"Chief Financial Officer","shares":9191,"price_per_share":5.1556,"usd_value":47385,"security_title":"Common Stock","importance":15.0473851196},{"ts":"2026-09-29","kind":"sec.insider.6727","reporter":"O'Malley Brendan M.","title":"SVP, Chief Legal Officer","shares":6727,"price_per_share":5.1556,"usd_value":34682,"security_title":"Common Stock","importance":15.0346817212},{"ts":"2026-09-29","kind":"sec.insider.4902","reporter":"Vasanthavada Madhav","title":"Chief Commercial Officer","shares":4902,"price_per_share":5.1556,"usd_value":25273,"security_title":"Common Stock","importance":15.0252727512},{"ts":"2026-09-15","kind":"sec.filing","form_type":"8-K","title":"8-K — ABEONA THERAPEUTICS INC. — 2026-09-15","url_slug":"/sec/cik-0000318306/8-k/0001493152-26-042702","accession_number":"0001493152-26-042702","importance":35},{"ts":"2026-08-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — ABEONA THERAPEUTICS INC. — 2026-08-13","url_slug":"/sec/cik-0000318306/10-q/0001493152-26-037576","accession_number":"0001493152-26-037576","importance":45},{"ts":"2026-08-13","kind":"sec.filing","form_type":"8-K","title":"8-K — ABEONA THERAPEUTICS INC. — 2026-08-13","url_slug":"/sec/cik-0000318306/8-k/0001493152-26-037575","accession_number":"0001493152-26-037575","importance":35},{"ts":"2026-07-21","kind":"sec.insider.s","reporter":"Vazzano Joseph Walter","title":"Chief Financial Officer","shares":1478,"price_per_share":6.53,"usd_value":9651,"security_title":"Common Stock","importance":35.00965134},{"ts":"2026-07-10","kind":"sec.filing","form_type":"424B3","title":"424B3 — ABEONA THERAPEUTICS INC. — 2026-07-10","url_slug":"/sec/cik-0000318306/424b3/0001493152-26-032852","accession_number":"0001493152-26-032852","importance":30},{"ts":"2026-07-09","kind":"sec.form144","reporter":"Seshadri Vishwas","title":"Officer","shares":67971,"usd_value":473330,"security_title":"Common Stock","approx_sale_date":"2026-07-09","accession_number":"0001972481-26-000232","importance":40.094666},{"ts":"2026-07-09","kind":"sec.form144","reporter":"Vazzano Joseph Walter","title":"Officer","shares":24880,"usd_value":173257,"security_title":"Common Stock","approx_sale_date":"2026-07-09","accession_number":"0001972481-26-000230","importance":40.0346514},{"ts":"2026-07-09","kind":"sec.form144","reporter":"Vasanthavada Madhav","title":"Officer","shares":12606,"usd_value":87784,"security_title":"Common Stock","approx_sale_date":"2026-07-09","accession_number":"0001972481-26-000231","importance":40.0175568},{"ts":"2026-07-09","kind":"sec.form144","reporter":"O'Malley Brendan M.","title":"Officer","shares":12050,"usd_value":83913,"security_title":"Common Stock","approx_sale_date":"2026-07-09","accession_number":"0001972481-26-000229","importance":40.0167826},{"ts":"2026-07-09","kind":"sec.insider.s","reporter":"Seshadri Vishwas","title":"Chief Executive Officer","shares":67971,"price_per_share":6.9637,"usd_value":473330,"security_title":"Common Stock","importance":35.4733296527},{"ts":"2026-07-09","kind":"sec.insider.s","reporter":"Vazzano Joseph Walter","title":"Chief Financial Officer","shares":24880,"price_per_share":6.9637,"usd_value":173257,"security_title":"Common Stock","importance":35.173256856},{"ts":"2026-07-09","kind":"sec.insider.s","reporter":"Vasanthavada Madhav","title":"Chief Commercial Officer","shares":12606,"price_per_share":6.9637,"usd_value":87784,"security_title":"Common Stock","importance":35.0877844022},{"ts":"2026-07-09","kind":"sec.insider.s","reporter":"O'Malley Brendan M.","title":"SVP, Chief Legal Officer","shares":12050,"price_per_share":6.9637,"usd_value":83913,"security_title":"Common Stock","importance":35.083912585},{"ts":"2026-07-06","kind":"sec.form144","reporter":"Silverstein Christine Berni","title":"Former Director","shares":102180,"usd_value":640771,"security_title":"Common Stock","approx_sale_date":"2026-07-06","accession_number":"0001972481-26-000224","importance":40.1281542},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Alland Leila","title":"","shares":11000,"price_per_share":5.917,"usd_value":65087,"security_title":"Common Stock","importance":35.065087},{"ts":"2026-06-26","kind":"sec.filing","form_type":"S-8","title":"S-8 — ABEONA THERAPEUTICS INC. — 2026-06-26","url_slug":"/sec/cik-0000318306/s-8/0001493152-26-030313","accession_number":"0001493152-26-030313","importance":30},{"ts":"2026-06-16","kind":"sec.insider.j","reporter":"Vasanthavada Madhav","title":"Chief Commercial Officer","shares":222,"price_per_share":5.67,"usd_value":1259,"security_title":"Common Stock","importance":15.00125874},{"ts":"2026-06-15","kind":"sec.form144","reporter":"Silverstein Christine Berni","title":"Director","shares":18160,"usd_value":103695,"security_title":"Common Stock","approx_sale_date":"2026-06-15","accession_number":"0001972481-26-000201","importance":40.020739},{"ts":"2026-06-15","kind":"sec.insider.s","reporter":"Silverstein Christine Berni","title":"","shares":18160,"price_per_share":5.7101,"usd_value":103695,"security_title":"Common Stock","importance":35.103695416},{"ts":"2026-06-12","kind":"sec.filing","form_type":"8-K","title":"8-K — ABEONA THERAPEUTICS INC. — 2026-06-12","url_slug":"/sec/cik-0000318306/8-k/0001493152-26-028369","accession_number":"0001493152-26-028369","importance":35},{"ts":"2026-06-12","kind":"sec.filing","form_type":"8-K","title":"8-K — ABEONA THERAPEUTICS INC. — 2026-06-12","url_slug":"/sec/cik-0000318306/8-k/0001493152-26-028458","accession_number":"0001493152-26-028458","importance":35},{"ts":"2026-06-10","kind":"sec.filing","form_type":"8-K","title":"8-K — ABEONA THERAPEUTICS INC. — 2026-06-10","url_slug":"/sec/cik-0000318306/8-k/0001493152-26-028106","accession_number":"0001493152-26-028106","importance":35},{"ts":"2026-06-09","kind":"sec.form144","reporter":"Vazzano Joseph Walter","title":"Officer","shares":25646,"usd_value":138288,"security_title":"Common Stock","approx_sale_date":"2026-06-09","accession_number":"0001972481-26-000188","importance":40.0276576},{"ts":"2026-06-09","kind":"sec.insider.s","reporter":"Seshadri Vishwas","title":"Chief Executive Officer","shares":31916,"price_per_share":5.3042,"usd_value":169289,"security_title":"Common Stock","importance":35.1692888472},{"ts":"2026-06-09","kind":"sec.insider.s","reporter":"Vazzano Joseph Walter","title":"Chief Financial Officer","shares":25646,"price_per_share":5.3922,"usd_value":138288,"security_title":"Common Stock","importance":35.1382883612},{"ts":"2026-06-09","kind":"sec.insider.s","reporter":"Vazzano Joseph Walter","title":"Chief Financial Officer","shares":13421,"price_per_share":5.3042,"usd_value":71188,"security_title":"Common Stock","importance":35.0711876682},{"ts":"2026-06-09","kind":"sec.insider.s","reporter":"O'Malley Brendan M.","title":"SVP, Chief Legal Officer","shares":6305,"price_per_share":5.3042,"usd_value":33443,"security_title":"Common Stock","importance":35.033442981},{"ts":"2026-06-09","kind":"sec.insider.s","reporter":"Vasanthavada Madhav","title":"Chief Commercial Officer","shares":5450,"price_per_share":5.3042,"usd_value":28908,"security_title":"Common Stock","importance":35.02890789},{"ts":"2026-06-08","kind":"sec.form144","reporter":"Seshadri Vishwas","title":"Officer","shares":58000,"usd_value":304500,"security_title":"Common Stock","approx_sale_date":"2026-06-08","accession_number":"0001972481-26-000185","importance":40.0609},{"ts":"2026-06-08","kind":"sec.form144","reporter":"Vazzano Joseph Walter","title":"Officer","shares":25000,"usd_value":131250,"security_title":"Common Stock","approx_sale_date":"2026-06-08","accession_number":"0001972481-26-000184","importance":40.02625},{"ts":"2026-06-08","kind":"sec.form144","reporter":"O'Malley Brendan M.","title":"Officer","shares":12000,"usd_value":63000,"security_title":"Common Stock","approx_sale_date":"2026-06-08","accession_number":"0001972481-26-000186","importance":40.0126},{"ts":"2026-06-08","kind":"sec.form144","reporter":"Vasanthavada Madhav","title":"Officer","shares":10000,"usd_value":52500,"security_title":"Common Stock","approx_sale_date":"2026-06-08","accession_number":"0001972481-26-000187","importance":40.0105},{"ts":"2026-06-08","kind":"sec.insider.s","reporter":"Seshadri Vishwas","title":"Chief Executive Officer","shares":24428,"price_per_share":5.4295,"usd_value":132632,"security_title":"Common Stock","importance":35.132631826},{"ts":"2026-06-08","kind":"sec.insider.s","reporter":"Vazzano Joseph Walter","title":"Chief Financial Officer","shares":10271,"price_per_share":5.4295,"usd_value":55766,"security_title":"Common Stock","importance":35.0557663945},{"ts":"2026-06-08","kind":"sec.insider.s","reporter":"O'Malley Brendan M.","title":"SVP, Chief Legal Officer","shares":4826,"price_per_share":5.4295,"usd_value":26203,"security_title":"Common Stock","importance":35.026202767},{"ts":"2026-06-08","kind":"sec.insider.s","reporter":"Vasanthavada Madhav","title":"Chief Commercial Officer","shares":4170,"price_per_share":5.4295,"usd_value":22641,"security_title":"Common Stock","importance":35.022641015},{"ts":"2026-06-04","kind":"sec.filing","form_type":"8-K","title":"8-K — ABEONA THERAPEUTICS INC. — 2026-06-04","url_slug":"/sec/cik-0000318306/8-k/0001493152-26-027197","accession_number":"0001493152-26-027197","importance":35},{"ts":"2026-05-15","kind":"sec.form144","reporter":"Crombez Eric","title":"Director","shares":26143,"usd_value":144636,"security_title":"Common Stock","approx_sale_date":"2026-05-15","accession_number":"0001972481-26-000161","importance":40.0289272},{"ts":"2026-05-15","kind":"sec.insider.s","reporter":"Crombez Eric","title":"","shares":26143,"price_per_share":5.5325,"usd_value":144636,"security_title":"Common Stock","importance":35.1446361475},{"ts":"2026-05-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — ABEONA THERAPEUTICS INC. — 2026-05-13","url_slug":"/sec/cik-0000318306/10-q/0001493152-26-022614","accession_number":"0001493152-26-022614","importance":45},{"ts":"2026-05-13","kind":"sec.filing","form_type":"8-K","title":"8-K — ABEONA THERAPEUTICS INC. — 2026-05-13","url_slug":"/sec/cik-0000318306/8-k/0001493152-26-022610","accession_number":"0001493152-26-022610","importance":35},{"ts":"2026-04-27","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — ABEONA THERAPEUTICS INC. — 2026-04-27","url_slug":"/sec/cik-0000318306/def-14a/0001493152-26-019153","accession_number":"0001493152-26-019153","importance":40},{"ts":"2026-04-27","kind":"sec.filing","form_type":"ARS","title":"ARS — ABEONA THERAPEUTICS INC. — 2026-04-27","url_slug":"/sec/cik-0000318306/ars/0001493152-26-019156","accession_number":"0001493152-26-019156","importance":30}]}